New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

The Medication IntelligenceTM Company, BluesightR, today released the findings of a recent survey evaluating American consumers' trust in the country's healthcare system and pharmaceutical sector, which found that both have below-average levels of trust. The study also looked at how patient perception and judgments about where to get care may be influenced by prior knowledge of drug diversion, among other things. According to Kevin MacDonald, CEO and co-founder of Bluesight, "Through our portfolio of software products, Bluesight intends to provide actionable analytics by removing the hurdles of siloed data within hospitals." "At the end of the day, hospitals care most about patient safety and their viewpoints. By highlighting important aspects that affect patients' decisions when selecting their doctors, this poll brings the voice of the patient to life.